chloroquine has been researched along with carbobenzoxycarbonyl-l-phenylalanyl-l-alanine-d-diazomethane in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, X; Lynch, G; Zhou, J | 1 |
Bahr, BA; Bendiske, J | 1 |
2 other study(ies) available for chloroquine and carbobenzoxycarbonyl-l-phenylalanyl-l-alanine-d-diazomethane
Article | Year |
---|---|
Lysosomal protease inhibitors induce meganeurites and tangle-like structures in entorhinohippocampal regions vulnerable to Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Cathepsin B; Cathepsin L; Cathepsins; Chloroquine; Cysteine Endopeptidases; Diazomethane; Endopeptidases; Entorhinal Cortex; Hippocampus; Humans; Lysosomes; Neurites; Neurofibrillary Tangles; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Serine Proteinase Inhibitors | 1999 |
Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis--an approach for slowing Alzheimer disease?
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cathepsins; Chloroquine; Culture Techniques; Cysteine Proteinase Inhibitors; Diazomethane; Disease Models, Animal; Enzyme Activation; Hippocampus; Hydrolases; Lysosomes; Rats; Rats, Sprague-Dawley; Synapses; tau Proteins | 2003 |